China’s Clover raises $230 million, plans vaccines for COVID-19 variants

China’s Clover Biopharmaceuticals, a developer of coronavirus vaccines, has raised $230 million from investors, including Singapore’s state investment firm Temasek Holdings, it said on Tuesday, as it …

Editorialista

• Geekvape and Paris Saint-Germain Announce Official Partnership
• Why should you try to use the best ethereum wallet and is bitcoin going down again?
• Eco Forum Global Guiyang 2021 kicks off

Set your Author Custom HTML Tab Content on your Profile page